Gastrointestinal stromal tumors: case series of 29 patients defining the role of imatinib prior to surgery.

World Journal of Surgery
Shailesh V ShrikhandeK M Mohandas

Abstract

The aim of this study was to assess the role of neoadjuvant imatinib in redefining treatment for gastrointestinal stromal tumors (GISTs). A total of 76 patients were reviewed. Among them, 29 patients who were administered neoadjuvant imatinib for borderline resectable and locally advanced GISTs followed by surgery were analyzed. Adjuvant imatinib was administered based on risk stratification. The median age of the neoadjuvant imatinib group was 51 years. The median duration of neoadjuvant imatinib administration was 8.5 months. The response rate with neoadjuvant imatinib was 79.3%. Five patients, initially considered to have locally unresectable lesions, ultimately underwent resection (three R0, two R2). Another three patients, who had M1 disease, underwent R2 resection (due to the presence of metastasis) with complete resection of the primary lesion. In 19 patients, who would have originally required extensive surgery, underwent conservative surgery (R0). In two patients, neoadjuvant imatinib did not influence the final procedure. The postoperative complication rate was 13.8%, and there were no postoperative deaths. There was one locoregional recurrence and two cases of distant metastasis. The 1-, 2-, and 3-year overall surviv...Continue Reading

References

Mar 1, 2002·The New England Journal of Medicine·Michelle A ElliottAyalew Tefferi
Jul 3, 2002·Human Pathology·Christopher D M FletcherSharon W Weiss
Jul 3, 2002·Human Pathology·Ronald P DematteoGeorge Demetri
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chandrajit P RautMonica M Bertagnolli
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles D BlankeHeikki Joensuu
Mar 14, 2008·Langenbeck's Archives of Surgery·Konrad Klaus RichterAnnelore Altendorf-Hofmann
Mar 24, 2009·Lancet·Ronald P DematteoUNKNOWN American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team
Dec 1, 2009·International Journal of Surgery·Gamal M Saied, Ahmed M Kensarah
Nov 4, 2010·Indian Journal of Pathology & Microbiology·Vasantha A LakshmiSusy Kurian
Mar 8, 2011·Journal of Surgical Oncology·Timothy L FrankelSandra L Wong
Apr 30, 2011·World Journal of Gastroenterology : WJG·Simone ArolfoMario Nano

❮ Previous
Next ❯

Citations

Aug 8, 2013·Journal of Gastrointestinal Cancer·T Reid
Jan 15, 2014·Langenbeck's Archives of Surgery·Ferdinando C M CananziSatvinder Mudan
Dec 30, 2014·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Shailesh V ShrikhandeGoura Shankar Rath
Nov 19, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S H TirumaniC P Raut
Sep 26, 2013·American Journal of Clinical Oncology·Jurriën StiekemaJohanna W van Sandick
Sep 26, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F C M CananziS Mudan
May 25, 2016·Journal of Gastrointestinal Cancer·Anant RamaswamyShailesh Shrikhande
Sep 9, 2016·South Asian Journal of Cancer·Nikhil Suresh GhadyalpatilSaklani Avanish
Oct 5, 2017·South Asian Journal of Cancer·M C Suresh BabuL K Rajeev

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.